Rate My Professor Kate Webber

Associate Professor Kate Webber, BSc (Med) MBBS (Hons 1) FRACP PhD, is a medical oncologist at Monash Health, where she serves as the stream lead for gynaecological cancer within the oncology unit. She holds an Adjunct Clinical Associate Professor position at Monash University in the School of Clinical Sciences at Monash Health. Webber graduated from the University of New South Wales in 2002 with first class honours, earning her BSc (Med) and MBBS. She completed her medical oncology specialty training at St George and Prince of Wales Hospitals in Sydney and was awarded Fellowship of the Royal Australasian College of Physicians in 2010. As the inaugural Survivorship Research Fellow at the National Centre for Cancer Survivorship at UNSW, she completed her PhD in 2016, examining long-term health and psychosocial issues in cancer survivors and novel models of survivorship care. Before joining Monash Health in late 2018, she held staff specialist appointments in medical oncology at Prince of Wales Hospital and the Royal Hospital for Women in Sydney, an honorary appointment at Sydney Children’s Hospital, and a conjoint lecturer role at UNSW. She also served as Clinical Superintendent for Medicine, co-Director of Advanced Physician Training at Prince of Wales Hospital, and convenor of the UNSW Human Research Ethics Advisory Panel (Biomedical).

Webber has subspecialty expertise in breast and gynaecological cancers, cancer survivorship, and patient-reported outcomes research. Her research investigates the prevalence, predictors, and trajectories of physical and psychological symptoms following cancer treatment, lifestyle and behavioural interventions, novel delivery models for survivorship care, and the incorporation of real-time patient-reported outcome measures into standard cancer treatment. An active member of the Australia and New Zealand Gynaecological Oncology Group (ANZGOG), she has been an investigator on over 40 gynaecological cancer clinical trials and leads a research team at Monash Health. She has contributed to translating clinical trial evidence into practice as co-chair of the Cancer Institute NSW eviQ Medical Oncology Reference Committee from 2019 to 2023, deputy chair of the Clinical Oncology Society of Australia Survivorship Group, and member of its Patient Reported Outcomes Working Group. Notable awards include the Best Oral Abstract award in March 2014, Cancer Research Award in 2013, and the United Medical Protection Prize in Health Law and Ethics in 1999. Key publications include "Patient-reported outcomes (PROs) as personalised cancer care: report from a 2023 Australian consensus meeting (PROActive)" (eClinicalMedicine, 2025), "Providing Outpatient Oncology Mental Health Support: Understanding Staff Perspectives" (Psycho-Oncology, 2025), "Evaluating the impact of a tertiary multidisciplinary meeting in metastatic breast cancer: A prospective study" (The Breast, 2025), and "Aligning kidney function assessment in patients with cancer to global practices in internal medicine" (eClinicalMedicine, 2025).